Literature DB >> 475359

Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.

D F Welch, M T Kelly.   

Abstract

A total of 24 strains of the Mycobacterium fortuitum complex were tested for susceptibility to antimicrobial agents by the disk diffusion and agar dilution techniques. By comparing zones of inhibition obtained with the disk diffusion technique with results of minimal inhibitory concentration determinations, it was shown that disk diffusion results could predict in vitro susceptibility to selected antimicrobial agents. All of 17 strains of M. fortuitum were susceptible to </=1 mug of amikacin per ml. The corresponding average zone of inhibition around a 10-mug amikacin disk was 37 mm. Seven M. chelonei strains were more resistant to amikacin, with minimal inhibitory concentrations ranging from 1 to 32 mug/ml, and the corresponding average zone size was 21 mm. Susceptibility of both M. fortuitum and M. chelonei to tetracycline was variable and none of the M. chelonei strains was inhibited by polymyxin B, whereas M. fortuitum strains consistently had zones of inhibition around the polymyxin disk. It appears that identification to species of the M. fortuitum complex may be of importance with regard to antibiotic susceptibility. Separation of M. fortuitum and M. chelonei was readily accomplished in the present study by the nitrate reduction and 3-day arylsulfatase tests.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475359      PMCID: PMC352753          DOI: 10.1128/AAC.15.6.754

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  GRANULOMA OF THE SKIN DUE TO MYCOBACTERIUM FORTUITUM.

Authors:  E SHOCKET; R E DROSD; C F TATE
Journal:  South Med J       Date:  1964-11       Impact factor: 0.954

2.  Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.

Authors:  W E Sanders; E C Hartwig; N J Schneider; R Cacciatore; H Valdez
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases.

Authors:  R B Dreisin; C Scoggin; P T Davidson
Journal:  Tubercle       Date:  1976-03

4.  Diagnostic key to mycobacteria encountered in clinical laboratories.

Authors:  L G Wayne; J R Doubek
Journal:  Appl Microbiol       Date:  1968-06

5.  Infection caused by Mycobacterium fortuitum.

Authors:  R C Offer; A G Karlson; J A Spittell
Journal:  Mayo Clin Proc       Date:  1971-11       Impact factor: 7.616

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Mycobacterium fortuitum--a human pathogen.

Authors:  W L Hand; J P Sanford
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

8.  Infection of prosthetic arthroplasty by Mycobacterium fortuitum. Two case reports.

Authors:  J E Booth; J A Jacobson; T A Kurrus; T W Edwards
Journal:  J Bone Joint Surg Am       Date:  1979-03       Impact factor: 5.284

9.  In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.

Authors:  J R Dalovisio; G A Pankey
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

  9 in total
  13 in total

1.  Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.

Authors:  S E Hoffner; L Klintz; B Olsson-Liljequist; A Bolmström
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

2.  Isolation of Mycobacterium chelonei with the lysis-centrifugation blood culture technique.

Authors:  M F Fojtasek; M T Kelly
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

3.  In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.

Authors:  M H Cynamon; A Patapow
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

4.  Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.

Authors:  R J Wallace; J M Swenson; V A Silcox; R C Good
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

5.  Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.

Authors:  M S Stone; R J Wallace; J M Swenson; C Thornsberry; L A Christensen
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

6.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  J M Swenson; R J Wallace; V A Silcox; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

7.  Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae.

Authors:  L C Steele; R J Wallace
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

8.  Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.

Authors:  J M Swenson; C Thornsberry; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

9.  In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.

Authors:  M J Casal; F C Rodriguez; M C Benavente
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

10.  Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Authors:  R J Wallace; J R Dalovisio; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.